Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000004

PRESIDENT AND COO sold 14,625 shares at an average $487.38 ($7,127,877)

  • PRESIDENT AND COO acquired 14,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Option exercise 10b5-1 +14,625 $117.76 $1,722,240 14,625 I: show line 1 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −697 $480.68 $335,035 13,928 I: show line 2 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −1,657 $481.86 $798,446 12,271 I: show line 3 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −873 $482.72 $421,414 11,398 I: show line 4 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −697 $483.80 $337,212 10,701 I: show line 5 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −1,169 $485.00 $566,959 9,532 I: show line 6 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −1,669 $486.05 $811,217 7,863 I: show line 7 in the form
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Sale 10b5-1 −856 $487.40 $417,218 7,007 I: show line 8 in the form
Open-market sales · 14,625 sh · avg $487.38 · $7,127,877

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BENKOWITZ MICHAEL PRESIDENT AND COO 2026-01-05 Option exercise · Stock Options 10b5-1 −14,625 97,125 I: show line 16 in the form
Loading xslF345X05/primarydocument.xml…